Final ID: MDP110
Salamatbad Gidon, Palati Sai, Lin Kuan-yu, Leung Christian, Wang Cassie, Jassal Ajay, Li Shuojohn, Guntaka Saimanoj, Chang Joshua, Jnani Jack, Patel Pushpendra, Cyr Andrew, Weintraub Spencer, Griffin Matthew, Alvarez Villela Miguel, Pierce Matthew, Shknevskiy Shusterman Vlad, Bhatt Madhav, Suleman Saman, Nuvvula Sri, Lin Allan, Dahal Kripa, Elkhechen Nader
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor